An Exploratory, Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of BYM338 on Muscle in Patients Requiring Prolonged Mechanical Ventilation

Trial Profile

An Exploratory, Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of BYM338 on Muscle in Patients Requiring Prolonged Mechanical Ventilation

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Bimagrumab (Primary)
  • Indications Muscular atrophy
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 23 Mar 2017 Status changed from recruiting to Discontinued as reported by European Clinical Trials Database record.
    • 19 Jun 2014 Planned End Date changed from 1 Nov 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
    • 08 Apr 2014 New source identified and integrated European Clinical Trials Database; EudraCT2013-002201-66
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top